These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14602918)

  • 1. p53 stimulates human topoisomerase I activity by modulating its DNA binding.
    Søe K; Grosse F
    Nucleic Acids Res; 2003 Nov; 31(22):6585-92. PubMed ID: 14602918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro.
    Stephan H; Grosse F; Søe K
    Nucleic Acids Res; 2002 Dec; 30(23):5087-93. PubMed ID: 12466531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.
    Søe K; Hartmann H; Schlott B; Stevnsner T; Grosse F
    Oncogene; 2002 Sep; 21(43):6614-23. PubMed ID: 12242659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular stress triggers the human topoisomerase I damage response independently of DNA damage in a p53 controlled manner.
    Rockstroh A; Kleinert A; Kramer M; Grosse F; Søe K
    Oncogene; 2007 Jan; 26(1):123-31. PubMed ID: 16799632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro.
    Søe K; Dianov G; Nasheuer HP; Bohr VA; Grosse F; Stevnsner T
    Nucleic Acids Res; 2001 Aug; 29(15):3195-203. PubMed ID: 11470877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of DNA topoisomerase I activity by p53.
    Gobert C; Bracco L; Rossi F; Olivier M; Tazi J; Lavelle F; Larsen AK; Riou JF
    Biochemistry; 1996 May; 35(18):5778-86. PubMed ID: 8639538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.
    Gobert C; Skladanowski A; Larsen AK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10355-60. PubMed ID: 10468612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants.
    Albor A; Kaku S; Kulesz-Martin M
    Cancer Res; 1998 May; 58(10):2091-4. PubMed ID: 9605749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53.
    Baumann C; Boehden GS; Bürkle A; Wiesmüller L
    Nucleic Acids Res; 2006; 34(3):1036-49. PubMed ID: 16473854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 dependence of topoisomerase I recruitment in vivo.
    Mao Y; Okada S; Chang LS; Muller MT
    Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.
    Delgado JL; Lentz SRC; Kulkarni CA; Chheda PR; Held HA; Hiasa H; Kerns RJ
    Eur J Med Chem; 2019 Jun; 172():109-130. PubMed ID: 30959322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of ATP to human DNA topoisomerase I resulting in an alteration of the conformation of the enzyme.
    Chen HJ; Hwang J
    Eur J Biochem; 1999 Oct; 265(1):367-75. PubMed ID: 10491194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53.
    Larsen AK; Gobert C; Gilbert C; Markovits J; Bojanowski K; Skladanowski A
    Acta Biochim Pol; 1998; 45(2):535-44. PubMed ID: 9821882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
    Tomicic MT; Christmann M; Kaina B
    Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein.
    Carey JF; Schultz SJ; Sisson L; Fazzio TG; Champoux JJ
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5640-5. PubMed ID: 12711735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status.
    Mao Y; Mehl IR; Muller MT
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1235-40. PubMed ID: 11805286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of minimal catalytic fragments of topoisomerase V reveals conformational changes relevant for DNA binding.
    Rajan R; Taneja B; Mondragón A
    Structure; 2010 Jul; 18(7):829-38. PubMed ID: 20637419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A first view of the structure of a type IA topoisomerase with bound DNA.
    Champoux JJ
    Trends Pharmacol Sci; 2002 May; 23(5):199-201. PubMed ID: 12007989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human topoisomerase I forms double cleavage complexes on natural DNA.
    Søe K; Hartung S; Grosse F
    Biochem Biophys Res Commun; 2006 Oct; 349(1):178-85. PubMed ID: 16930551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerase III alpha regulates p53-mediated tumor suppression.
    Hsieh MY; Fan JR; Chang HW; Chen HC; Shen TL; Teng SC; Yeh YH; Li TK
    Clin Cancer Res; 2014 Mar; 20(6):1489-501. PubMed ID: 24526736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.